STSA-1005 / Staidson Biopharma 
Welcome,         Profile    Billing    Logout  
  Diseases    Trials    Trials    News 
1 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
STSA-1005 / Staidson Biopharma
NCT05559125: A Study of STSA-1002 Combined With STSA-1005 in Healthy Subjects

Terminated
1
50
RoW
STSA-1002 Injection, STSA-1005 Injection
Staidson (Beijing) Biopharmaceuticals Co., Ltd
Healthy Subject
03/24
03/24

Download Options